Last10K.com

Advansource Biomaterials Corp (ASNB) SEC Filing 10-Q Quarterly report for the period ending Tuesday, December 31, 2019

SEC Filings

ASNB Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ASNB Annual Reports

ASNB Quarterly Reports

ASNB Corporate News

Advansource Biomaterials Corp

HISTORY TOOLS
CIK: 1499961 Ticker: ASNB
Document and Entity Information - shares
9 Months Ended
Dec. 31, 2019
Apr. 01, 2020
Cover [Abstract]  
Entity Registrant NameAdvanSource Biomaterials Corp 
Entity Central Index Key0001011060 
Document Type10-Q 
Document Period End DateDec. 31, 2019 
Amendment Flagfalse 
Current Fiscal Year End Date--03-31 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Business Flagtrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 28,262,371
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2020 

View differences made from one quarter to another to evaluate Advansource Biomaterials Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advansource Biomaterials Corp.

Continue

Assess how Advansource Biomaterials Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advansource Biomaterials Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Balance Sheets
Balance Sheets (Parenthetical)
Statement Of Stockholders' Deficit (Unaudited)
Statements Of Cash Flows (Unaudited)
Statements Of Operations (Unaudited)
Business Description
Business Description (Details Narrative)
Concentrations Of Credit Risk And Major Customers
Concentrations Of Credit Risk And Major Customers (Details Narrative)
Going Concern
Held For Sale Assets And Liabilities And Discontinued Operations
Held For Sale Assets And Liabilities And Discontinued Operations (Details Narrative)
Held For Sale Assets And Liabilities And Discontinued Operations (Tables)
Held For Sale Assets And Liabilities And Discontinued Operations - Schedule Of Components Of Assets Held-For-Sale (Details)
Held For Sale Assets And Liabilities And Discontinued Operations - Schedule Of Discontinued Operations (Details)
Income Per Share
Income Per Share (Details Narrative)
Income Taxes
Income Taxes (Details Narrative)
Interim Financial Statements And Basis Of Presentation
Legal Proceedings
Long-Term Financing Obligation
Long-Term Financing Obligation (Details Narrative)
Promissory Notes
Promissory Notes (Details Narrative)
Recent Accounting Pronouncements
Related Party Transactions
Related Party Transactions (Details Narrative)
Stock-Based Compensation
Stock-Based Compensation (Details Narrative)
Stock-Based Compensation (Tables)
Stock-Based Compensation - Schedule Of Black-Scholes Pricing Model Assumptions (Details)
Stock-Based Compensation - Schedule Of Stock Option Activity (Details)
Stockholders' Deficit
Stockholders' Deficit (Details Narrative)
Subsequent Events
Subsequent Events (Details Narrative)

Material Contracts, Statements, Certifications & more

Advansource Biomaterials Corp provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: ASNB
CIK: 1011060
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-20-005627
Submitted to the SEC: Wed Apr 01 2020 5:02:17 PM EST
Accepted by the SEC: Wed Apr 01 2020
Period: Tuesday, December 31, 2019
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/asnb/0001493152-20-005627.htm